SHUFRO ROSE & CO LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHUFRO ROSE & CO LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2021$288,000
-5.3%
1,300
-43.5%
0.02%
-8.3%
Q1 2021$304,000
-46.8%
2,300
-30.3%
0.02%
-50.0%
Q4 2020$571,000
+55.6%
3,3000.0%0.05%
+33.3%
Q3 2020$367,000
+81.7%
3,300
+10.0%
0.04%
+50.0%
Q1 2020$202,000
-60.6%
3,000
-50.8%
0.02%
-47.8%
Q4 2019$513,000
-4.8%
6,100
-15.3%
0.05%
-14.8%
Q3 2019$539,0007,2000.05%
Other shareholders
NOVOCURE LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders